Alcon and Lensar are walking away from a proposed acquisition deal following pushback from the Federal Trade Commission (FTC) ...

Alcon and LENSAR have decided to terminate a previously agreed-upon merger due to scrutiny from the US Federal Trade Commission (FTC). 1,2. The merger, originally announced in Mar ...

Lensar is known for developing the Ally robotic cataract laser treatment system, alongside Streamline software technology and ...

ORLANDO, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the ...

LENSAR Inc. LNSR shares are down during Tuesday’s premarket session following the termination of a merger agreement with Alcon AG ALC. In March 2025, Alcon agreed to acquire the laser solutions ...

The Federal Trade Commission said the transaction had threatened to raise prices and stifle innovation for cataract laser eye ...

Lensar (LNSR) reached an agreement with Alcon (ALC) to terminate its planned sale. The parties are abandoning the deal as the ...

Lensar today entered into a priority credit line agreement in a move that analysts say casts doubt over its planned acquisition by Alcon.

Lensar (Nasdaq:LNSR) announced today that it reached an agreement with Alcon (NYSE:ALC) to terminate their planned merger.

Data on Alcon’s products across cataract, refractive, diagnostics and ocular health will be featured in presentations during the meeting Prospective analyses and studies demonstrate sustained ...

“Alcon has a long legacy of advancing phaco and vitreoretinal technology for surgical ophthalmology. With UNITY VCS/CS, we are introducing more than a dozen innovations designed to transform surgical ...